Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals
预测未来：福泰制药的13名分析师的预测
In the preceding three months, 13 analysts have released ratings for Vertex Pharmaceuticals (NASDAQ:VRTX), presenting a wide array of perspectives from bullish to bearish.
在过去的三个月中，有13位分析师针对福泰制药（纳斯达克：VRTX）发布了评级，呈现了从看好到淡漠的广泛观点。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析师最近的评级概述，为了全面了解过去30天的情绪变化并与前几个月进行比较，提供了深入的见解。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $477.54, a high estimate of $555.00, and a low estimate of $421.00. This current average has increased by 4.91% from the previous average price target of $455.18.
分析师评估的12个月价格目标揭示了更多信息，平均目标为$ 477.54，最高估值为$ 555.00，最低估值为$ 421.00。这个当前平均数比先前的平均价格目标$455.18增加了4.91％。
Exploring Analyst Ratings: An In-Depth...
分析师评级:...
登录免费看全文
登录/注册